<table><tr><th>From:</th><th>Nathan Wolfe &lt;</th></tr><tr><td>Sent:</td><td>Wednesday, April 17, 2013 8:04 PM</td></tr><tr><td>To:</td><td>Jeffrey Epstein</td></tr><tr><td>Subject:</td><td>Fwd:</td></tr></table>

Jeffrey

Below are some references that show how sexual behavior questionnaires have been validated. I believe these issues have been well addressed and am not concerned that we can get good data on changes in sexual behavior within individuals over time in relation to variables like the incidence of new STIs

Nathan

Forwarded <u>message</u>
From: Karen Saylors <
Date: Wed, Apr 17, 2013 at 12:55 PM
Subject: Re:
To: Nathan Wolfe <
Cc: Kasey Kissick <

The test-retest approach with a strong sexual behavior scale seems like the best way to screen:

	1) Test-retest reliability and predictors of unreliable reporting for a sexual behavior questionnaire for U.S. men. <http://www.ncbi.nlm.nih.gov/pubmed/19705273>

2) Test-retest reliability of self-reported HIV/STD-related measures among African-American adolescents in four U.S. cities.

<http://www.ncbi.nlm.nih.gov/pubmed/19237106>

Another approach is interpartner reliability/comparison, which would lead us in the direction of partner contact tracing:

3) Reliability of self-reported sexual histories: test-retest and interpartner comparison in a sexually transmitted diseases clinic.

<http://www.ncbi.nlm.nih.gov/pubmed/9918321>

4) Interpartner reliability of reporting of recent sexual behaviors. <http://www.ncbi.nlm.nih.gov/pubmed/1746526>

There are lots of standardized instruments on sexual behavior and STI transmission, including the National Survey of Family Growth and General Social Survey:

5) Sexual partnership patterns as a behavioral risk factor for sexually transmitted diseases. <http://www.ncbi.nlm.nih.gov/pubmed/10723647>

If we proceed with a cohort study, we can think further on how we would structure that.

Thanks,
Karen

On 4/17/13 12:13 PM, "Nathan Wolfe" <██████████████████████████> wrote:

http://www.ncbi.nlm.nih.gov/pubmed?LinkName=pubmed_pubmed&from_uid=1970
>527
>3
>
>

>Dr. Nathan Wolfe I Founder and CEO I Metabiota
>Email: | Office:
>metabiota.com

>

>Please note that Global Viral Forecasting Inc. (GVF Inc.) has changed
>its name to Metabiota and Global Viral Forecasting Initiative (GVFI) is
>now known as Global Viral. For more details, please see our
>websites: metabiota.com and globalviral.org. For information on my
>teaching and public engagement please see nathanwolfe.net.
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//EN" "http://www.apple.com/DTDs/PropertyList-1.O.dtd">
<plist version="1.0">
<clict>
<key>date-last-viewed</key>
creal>0.0</real>
<key>date-received</key>
<real>1366229036</real>
<key>flags</key>
<integer>8590195713</integer>
<key>original-mailbox</key>
<string>imap://jeevacation@imap.gmail.com/%5BGmail%5D/All%20Mail</string>
<key>remote-id</key>
<string>292403</string>
</dict>
</plist>